A registry-based study of prolonged symptomatic adverse events according to electronic Patient-Reported Outcomes (ePRO) in breast cancer patients after adjuvant chemotherapy
Not Applicable
Recruiting
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000045422
- Lead Sponsor
- Hoshi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who don't have personal electronic devices(smartphones, tablets, etc.)capable of ePRO 2. History of synchronous or metachronous malignancies 3. Patients with psychiatric illnesses or symptoms that seriously disturbs activities of daily life 4. Patients with dementia that seriously disturbs activities of daily life
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of prolonged symptomatic adverse events using ePRO 1 year after adjuvant chemotherapy (CTCAE 26 Items, PRO-CTCAE 50 Items, CiTAS 18 Items, Appearance etc.)
- Secondary Outcome Measures
Name Time Method